Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization

Chimeric antigen receptor (CAR) T cell therapies have achieved promising outcomes in several cancers; however, more challenging oncology indications may necessitate advanced antigen receptor designs and functions. Here we describe a bipartite receptor system composed of separate antigen-targeting an...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JCI Insight
Главные авторы: Leung, Wai-Hang, Gay, Joel, Martin, Unja, Garrett, Tracy E., Horton, Holly M., Certo, Michael T., Blazar, Bruce R., Morgan, Richard A., Gregory, Philip D., Jarjour, Jordan, Astrakhan, Alexander
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629089/
https://ncbi.nlm.nih.gov/pubmed/31039141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.124430
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы